{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:33:21Z","timestamp":1788863601150,"version":"build-2803163510"},"reference-count":7,"publisher":"Elsevier","isbn-type":[{"value":"9780128245675","type":"print"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/bs.pbr.2021.01.001","type":"book-chapter","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T03:00:34Z","timestamp":1611284434000},"page":"1-5","source":"Crossref","is-referenced-by-count":24,"title":["5-HT interaction with other neurotransmitters: An overview"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.pbr.2021.01.001_bb0010","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.pbr.2021.01.001_bb9000","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1124\/pr.118.015552","article-title":"International Union of Basic and Clinical Pharmacology. CX. Classification of receptors for 5-hydroxytryptamine; pharmacology and function","volume":"73","author":"Barnes","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/bs.pbr.2021.01.001_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108340","article-title":"Serotonin research: crossing scales and boundaries","volume":"181","author":"Di Giovanni","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2021.01.001_bb0030","series-title":"Serotonin\u2013Dopamine Interaction: Experimental Evidence and Therapeutic Relevance","year":"2008"},{"key":"10.1016\/bs.pbr.2021.01.001_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108099","article-title":"Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: focus on 5-HT6 and D3 receptors as hubs","volume":"177","author":"Millan","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2021.01.001_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108155","article-title":"Central 5-HT receptors and their function; present and future","volume":"177","author":"Sharp","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2021.01.001_bb9005","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3389\/fnins.2016.00492","article-title":"Monoaminergic mechanisms in epilepsy may offer innovative therapeutic opportunity for monoaminergic multi-target drugs","volume":"10","author":"Svob Strac","year":"2016","journal-title":"Front. Neurosci."}],"container-title":["Progress in Brain Research","5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance - Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612321000017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612321000017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T08:45:44Z","timestamp":1753260344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079612321000017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780128245675"],"references-count":7,"URL":"https:\/\/doi.org\/10.1016\/bs.pbr.2021.01.001","relation":{},"ISSN":["0079-6123"],"issn-type":[{"value":"0079-6123","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}